Live from the NIH registry
Studies recruiting near Oklahoma City right now
Top 25 of 643 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Evaluation of the MuSICCA for Measuring Awareness
Disorder of Consciousness
N/A
Observational 80 participants sought
Bethany Children's Health Centre — Bethany, Oklahoma (7.6 mi)
· Sponsor: The Children's Trust, United Kingdom
The Effect of NAD Supplementation on Brain Vascular Health in Aging
Aging
Phase 4
Interventional 214 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: University of Oklahoma
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: NRG Oncology
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Phase 1, Phase 2
Interventional 460 participants sought
OU Health University of Oklahoma Medical Center ( Site 7000) — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Sameek Roychowdhury
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Oklahoma City, OK — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Mediar Therapeutics
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Dren Bio
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
HNSCC, ESCC
Phase 1
Interventional 150 participants sought
Normunity Investigational Site — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Normunity AccelCo, Inc.
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Local Institution - 0418 — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Bristol-Myers Squibb
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Thrombotic Thrombocytopenic Purpura, Congenital Thrombotic Thrombocytopenic Purpura
N/A
Observational 450 participants sought
University of Oklahoma Health Sciences Center, Department of Medicine, PO Box 26901 — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Insel Gruppe AG, University Hospital Bern
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Hospital Oklahoma City — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Advanced or Metastatic Colorectal Cancer
Phase 1, Phase 2
Interventional 225 participants sought
Stephenson Cancer Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Janssen Research & Development, LLC
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy
N/A
Interventional 105 participants sought
Oklahoma Heart Hospital — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Medtronic Cardiac Rhythm and Heart Failure
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 351 participants sought
OU Health Stephenson Cancer Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Fate Therapeutics
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: NRG Oncology
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
Lung Cancers
N/A
Observational 350 participants sought
Site 101 — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Everest Detection, Inc.
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Digestive Disease Specialists Inc — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Janssen Research & Development, LLC
The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer
Head and Neck Cancers
N/A
Observational 59 participants sought
Stephenson Cancer Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: University of Oklahoma
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
Lynn Health Science Institute — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Alveus Therapeutics, Inc.
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
Hemorrhoids
Phase 4
Interventional 100 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: University of Oklahoma
Spine Radiosurgery for Symptomatic Metastatic Neoplasms
Metastatic Neoplasm to the Spine, Metastatic Neoplasm
Phase 2
Interventional 240 participants sought
OU Health Stephenson Cancer Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: University of Oklahoma
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma
Phase 1
Interventional 65 participants sought
University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Low Grade Serous Ovarian Cancer
Phase 3
Interventional 270 participants sought
University of Oklahoma Medical Center — Oklahoma City, Oklahoma (0.2 mi)
· Sponsor: Verastem, Inc.
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Norman, Oklahoma (17.4 mi)
· Sponsor: TG Therapeutics, Inc.